Landos Biopharma Stock Price, News & Analysis
Company Description
Landos Biopharma (NASDAQ: LABP) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $71.7M, ranking #5,371 among all listed U.S. companies by market cap.
LABP stock has declined 100.0% over the past year. Shares last traded at $22.93.
This page provides a comprehensive overview of LABP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Landos Biopharma (LABP) stock last traded at $22.93. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $71.7M, LABP is classified as a micro-cap stock with approximately 3.1M shares outstanding.
Latest News
Landos Biopharma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, conferences, clinical trial. View all LABP news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LABP Company Profile & Sector Positioning
Landos Biopharma (LABP) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.